Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

Despite the staggering impact of obesity on the Black community, columnist Justice B. Hill argues that the issue has been ...

Body Mass Index (BMI) has limitations as it doesn't distinguish between muscle and fat, leading to misclassification of ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

Obesity is now understood as a condition that affects the functions of organs and tissues, leading to complications such as ...

The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same ...

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...

An international panel of researchers say the measure is too simplistic and focuses too much on weight versus wellness.

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

A panel of health experts looking at obesity announced that the definition of the condition should be split into two ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...